{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:18:52Z","timestamp":1778786332613,"version":"3.51.4"},"reference-count":25,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"unspecified","delay-in-days":904,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europsy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Eur. psychiatr."],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0924933800068450_abst0005\" sec-type=\"other\"><jats:title>Background:<\/jats:title><jats:p>Chronic hypertension has been associated with an increased risk of cognitive decline. Although a link between hypertension and cognitive decline has been established, there is less evidence supported by systematic reviews. The main aim was to compare different antihypertensive drug groups in relation to their effect on cognition in older patients without established dementia using a systematic review.<\/jats:p><\/jats:sec><jats:sec id=\"S0924933800068450_abst0010\" sec-type=\"methods\"><jats:title>Method:<\/jats:title><jats:p>A systematic search in Medline and Embase through to January 2017 was used to identify randomized controlled clinical trials (RCTs) studying the impact of different antihypertensives on cognition in older patients without dementia. Angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACE-Is), beta-blockers (BBs), diuretics, and calcium channel blockers (CCBs) were included in this review.<\/jats:p><\/jats:sec><jats:sec id=\"S0924933800068450_abst0015\" sec-type=\"results\"><jats:title>Results:<\/jats:title><jats:p>The systematic search identified 358\u00a0studies. The full text of 31\u00a0RCTs was reviewed and a total of 15\u00a0RCTs were included in the review. Most studies reported an improvement in episodic memory in patients treated with ARBs versus placebo or other types of antihypertensive drugs. No study showed an improvement in cognition in patients who received diuretics, BBs, or CCBs. Heterogeneity was high in most trials (predominantly in the blinding of participants and investigators).<\/jats:p><\/jats:sec><jats:sec id=\"S0924933800068450_abst0020\" sec-type=\"conclusions\"><jats:title>Conclusion:<\/jats:title><jats:p>This review suggests that ARBs can improve cognitive functions in the elderly, especially episodic memory. ACE-Is, diuretics, BBs and CCBs did not seem to improve cognitive function in the elderly but were similarly effective in blood pressure lowering as ARBs.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.eurpsy.2017.07.015","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T07:15:26Z","timestamp":1502781326000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Effects of different antihypertensive medication groups on cognitive function in older patients: A systematic review"],"prefix":"10.1017","volume":"46","author":[{"given":"M.","family":"Stuhec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Keuschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Serra-Mestres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Isetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"S0924933800068450_bib0100","first-page":"10","article-title":"Differential cognitive outcomes in the Hypertensive Old People in Edinburgh study","volume":"229","author":"Starr","year":"2005","journal-title":"J Neurol Sci"},{"key":"S0924933800068450_bib0025","first-page":"CD004034","article-title":"The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease","volume":"19","author":"McGuinness","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"S0924933800068450_bib0060","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32835fdf60"},{"key":"S0924933800068450_bib0020","first-page":"CD004034","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","volume":"4","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"S0924933800068450_bib0125","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"S0924933800068450_bib0115","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a35228"},{"key":"S0924933800068450_bib0065","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001964"},{"key":"S0924933800068450_bib0035","volume-title":"Cochrane handbook for systematic reviews of interventions version 5. 1. 0 (updated March 2011)","author":"Higgins","year":"2011"},{"key":"S0924933800068450_bib0040","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12100"},{"key":"S0924933800068450_bib0005","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0230-6"},{"key":"S0924933800068450_bib0050","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-8-615"},{"key":"S0924933800068450_bib0030","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"S0924933800068450_bib0095","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1988.tb04369.x"},{"key":"S0924933800068450_bib0105","first-page":"13","article-title":"Beta blockers and cognitive function in elderly hypertensive patients: withdrawal and consequences of ACE inhibitor substitution","volume":"2","author":"Hearing","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"S0924933800068450_bib0120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03784.x"},{"key":"S0924933800068450_bib0045","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70250-7"},{"key":"S0924933800068450_bib0090","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7034.801"},{"key":"S0924933800068450_bib0055","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70143-1"},{"key":"S0924933800068450_bib0085","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001613"},{"key":"S0924933800068450_bib0080","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000042"},{"key":"S0924933800068450_bib0015","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000244934.81180.16"},{"key":"S0924933800068450_bib0110","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32804c58aa"},{"key":"S0924933800068450_bib0070","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0717-9"},{"key":"S0924933800068450_bib0075","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000311447.85948.78"},{"key":"S0924933800068450_bib0010","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283603f53"}],"container-title":["European Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933817329577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933817329577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924933800068450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T08:26:43Z","timestamp":1584952003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924933800068450\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":25,"alternative-id":["S0924933800068450"],"URL":"https:\/\/doi.org\/10.1016\/j.eurpsy.2017.07.015","relation":{},"ISSN":["0924-9338","1778-3585"],"issn-type":[{"value":"0924-9338","type":"print"},{"value":"1778-3585","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of different antihypertensive medication groups on cognitive function in older patients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurpsy.2017.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}